FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileLakefront Biotherapeutics N.V.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
LKFT
Lakefront Biotherapeutics N.V. Stock AnalysisComprehensive stock analysis for Lakefront Biotherapeutics N.V. (LKFT) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisLKFT
LKFT
Lakefront Biotherapeutics N.V.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
LKFT
  1. Home
  2. Stocks
  3. Lakefront Biotherapeutics N.V.

Lakefront Biotherapeutics N.V.

🇺🇸LKFT•NASDAQ

Lakefront Biotherapeutics N.V.

🇺🇸LKFT•NASDAQ
Market cap
$2.18B
P/E ratio
4.11

Your view on LKFT

Mkt Cap
$2.18B
P/E
4.11
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Lakefront Biotherapeutics N.V.

Industry
Biotechnology
Sector
Healthcare
CEO
Henry O. Gosebruch
Headquarters
SchaliEnhoevedreef 20 T, Mechelen, BE
Industry
Biotechnology
Sector
Healthcare
CEO
Henry O. Gosebruch
Headquarters
SchaliEnhoevedreef 20 T, Mechelen, BE
Description

Galapagos NV is a biotechnology company that specializes in the discovery and advancement of novel small molecule and antibody-based therapeutics. Its active clinical development programs include drugs like filgotinib and GLP3667, alongside the Toledo program and therapies targeting idiopathic pulmonary fibrosis.

The firm was established on June 30, 1999, by co-founders Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es, and maintains its headquarters in Mechelen, Belgium.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Lakefront Biotherapeutics N.V.. Starting points for Lakefront Biotherapeutics N.V.: P/E 4.1, EPS $7.42, beta 0.12 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Lakefront Biotherapeutics N.V.. Trailing twelve-month EPS for Lakefront Biotherapeutics N.V. stands at $7.42. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Lakefront Biotherapeutics N.V.. Lakefront Biotherapeutics N.V. has reported as a listed company since 2005. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold LKFT12 companies
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
ELTXElicio Therapeutics, Inc.HealthcareNASDAQ$27.6M
ELUTElutia Inc.HealthcareNASDAQ$39.9M
ELVNEnliven Therapeutics, Inc.HealthcareNASDAQ$3.4B
EMMAEmmaus Life Sciences, Inc.HealthcareOTC$894,118
ENDVEndonovo Therapeutics, Inc.HealthcareOTC$31,875
ENGNenGene Holdings Inc.HealthcareNASDAQ$116.6M
ENGNWenGene Holdings Inc. WarrantsHealthcareNASDAQ$6.8M
ENLVEnlivex Therapeutics Ltd.HealthcareNASDAQ$17.7M
ENP.AXEntropy Neurodynamics LimitedHealthcareASX—
ENSCEnsysce Biosciences, Inc.HealthcareNASDAQ$7.0M
ENTAEnanta Pharmaceuticals, Inc.HealthcareNASDAQ$221.9M
ENTXEntera Bio Ltd.HealthcareNASDAQ$575.5M
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Lakefront Biotherapeutics N.V.. Coverage tracks Lakefront Biotherapeutics N.V. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Lakefront Biotherapeutics N.V.

LKFT AnalysisStrong
Past
3
Growth
5
Health
5
Profit
4
Value
5